6-Bromo-1-methyl-1H-benzimidazole
-
6-Bromo-1-methyl-1H-benzimidazole
structure -
-
CAS No:
53484-16-5
-
Formula:
C8H7BrN2
-
Chemical Name:
6-Bromo-1-methyl-1H-benzimidazole
-
Synonyms:
1H-Benzimidazole,6-bromo-1-methyl-;6-Bromo-1-methyl-1H-benzimidazole;1-Methyl-6-bromobenzimidazole;6-Bromo-1-methylbenzimidazole
-
CAS No:
Safety Information
22-37/38-41
26-39
Xi,Xn
Irritant
P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, P501
H315
|Warning|H302 (50%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 2 companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
6-Bromo-1-methyl-1H-benzimidazole Use and Manufacturing
To a solution of intermediate 2 (5g, 21.6mmol) in EtOH (200ml) was added portionwise SnCITo a solution of intermediate 2 (5g, 21.6mmol) in EtOH (200ml) was added portionwise SnClStep 3: 6-Bromo-l-methyl-117-benzoimidazole; [0311] To a suspension of (5-bromo-2-nitro-phenyl)-methyl-amine (1.2 g, 5.19 mmol) in ethanol (25 mL) was added tin(II) chloride (1.97 g, 10.39 mmol). The reaction mixture was stirred at 8O[0444j Step B: Preparation of 6-bromo-1-methyl-benzimidazole: A mixture of 5- bromo-N-methyl-2-nitro-aniline (6.0 g, 26 mmol), iron powder (14.5 g, 260 mmol), ammonium chloride (13.9 g, 260 mmol) and formic acid (49.0 mL, 1298 mmol) in 2- propanol (75 mL) was stirred under reflux for 24 hours. After cooling to ambient temperature, ethyl acetate (50 mL) was added. The solid was removed by filtering through a pad of celite. The filtrate was concentrated. Saturated sodium bicarbonate (20 mL) and ethyl acetate (50 mL) were added. The organic layer was separated, washed with brine, dried (sodium sulfate), filtered and concentrated. The residue was purified by flash chromatography on silica gel 10:1 ethyl acetate/MeOH to give 6-bromo-1-methyl-benzimidazole (5.35 g, 98percent) as solid.General procedure: A mixture of 8-(4-chlorophenyl)-2-((2, 2, 2- trifluoroethyl)amino)pyrido[4, 3-i/]pyrimi-din-7(d7/)-one (100 mg, 0.28 mmol, 1.0 equiv), 5-bromo-2-methyl-2H-indazole (119 mg, 0.56 mmol, 2.0 equiv.), Cul (5.4 mg, 0.028 mmol, 0.1 equiv.), N1, A2-dimethylcy cl ohexane-l, 2-diamine (8.1 mg, 0.056 mmol, 0.2 equiv.), CS2CO3 (276 mg, 0.847 mmol, 3.0 equiv.) and dioxane (2 mL) was stirred at l00C under N2 atmosphere for l6h. The crude mixture was concentrated under reduced pressure, and the resulting residue was purified by flash column chromatography on silica gel to yield 8-(4- chlorophenyl)-6-(2-methyl-2H-indazol-5-yl)-2-((2, 2, 2- tri fl uoroethyl )am i no)py ri do[-/, 3-6/]pyrimidin-7(6//)-one (Example 123).A mixture of 8-(4-chlorophenyl)-2-(2, 2, 2-trifluoroethylamino)- l, 6-naphthyridin-7(6f/)-one (50.0 mg, 0.14 mmol, 1.0 equiv.), Cul (26.6 mg, 0.14 mmol, 1.0 equiv.), CsF (63.8 mg, 0.4 mmol, 3.0 equiv.), N1N2- dimethylcy cl ohexane-l, 2-diamine (29.8 mg, 0.2 mmol, 1.5 equiv.), and 6- bromo-l -methyl- li7-benzo[A mixture of 6-bromo-1-methyl-1H-benzo[djimidazole 5 (20 g, 94.75 mmol), trimethyl acetylene (28 mL, 285.7 mmol), CuT (2.7 g, 14.28 mmol), TPP (1.25 g, 4.76 mmol), TEA (40 mL, 285.6 mmol) and Pd(PPh3)C12 (3.3 g, 4.76 mmol) in THF (200 mL) was heated to reflux for 16 h. The reaction mixture was concentrated under reduced pressure and the residue was purified by column chromatography (silica gel, eluent pet-ether/EtOAc 80:20) to give 1- methyl-6-((trimethylsilyl)ethynyl)- 1H-benzo [di imidazole (10 g, 36.34 mmol, LC-MS 83percent, 38.3percent) as a brown solid. 'H NMR (400 MHz, CDC13) (ppm): 7.88 (s, 1H), 7.70 (d, J = 8.4 Hz, 1H), 7.54 (s, 1H), 7.39 (dd, J= 0.8 Hz, 8.4 Hz, 1H), 3.82 (s, 3H), 0.27 (s, 9H); MS (ESI) m/z 229.3 [C, 3H, 6N2Si+Hjt
6-Bromo-1-methyl-1H-benzimidazole
SDSRequest for Quotation